Cargando…

Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation

OBJECTIVE: The purpose of this study was to investigate the factors predicting the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation (PAF) who underwent cryoablation of the pulmonary veins (PVs). METHODS: Fifty-one patients (54.6±10.4 years) with paroxysmal AF who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Menekşe Gerede, Demet, Candemir, Başar, Vurgun, Veysel Kutay, Aghdam, Siamak Mousavi, Acıbuca, Aynur, Özcan, Özgür Ulaş, Göksülük, Hüseyin, Kervancıoğlu, Celal, Erol, Çetin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331394/
https://www.ncbi.nlm.nih.gov/pubmed/26680545
http://dx.doi.org/10.5152/AnatolJCardiol.2015.6309
_version_ 1782511366978928640
author Menekşe Gerede, Demet
Candemir, Başar
Vurgun, Veysel Kutay
Aghdam, Siamak Mousavi
Acıbuca, Aynur
Özcan, Özgür Ulaş
Göksülük, Hüseyin
Kervancıoğlu, Celal
Erol, Çetin
author_facet Menekşe Gerede, Demet
Candemir, Başar
Vurgun, Veysel Kutay
Aghdam, Siamak Mousavi
Acıbuca, Aynur
Özcan, Özgür Ulaş
Göksülük, Hüseyin
Kervancıoğlu, Celal
Erol, Çetin
author_sort Menekşe Gerede, Demet
collection PubMed
description OBJECTIVE: The purpose of this study was to investigate the factors predicting the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation (PAF) who underwent cryoablation of the pulmonary veins (PVs). METHODS: Fifty-one patients (54.6±10.4 years) with paroxysmal AF who underwent the cryoablation of the PVs were to the prospective trial. The clinical risk factors and echocardiographic parameters [left atrial (LA) diameter, left ventricular ejection fraction and dimensions, left atrial spontaneous echo contrast (LASEC), mitral annulus calcification (MAC), left atrial appendage emptying peak flow velocity (LAAV), and PV flow] were assessed before the cryoablation procedure. Patients with PAF who refused to use any medication because of intolerance or presentation of resistant symptoms, despite the use of at least one antiarrhythmic drug were enrolled to the study, patients with LA/LAA thrombus on echocardiographic examination, severe valvular disease, pericardial fluid, and abnormal thyroid function tests as well as systemic disease were excluded from the study. All parameters were tested for their ability to predict the recurrence of AF during a 1-year follow-up period. RESULTS: During the period of follow-up, AF recurred in 16 of 51 patients (31.3%/year). All significant parameters associated with the recurrence of AF were evaluated in multivariate logistic regression analysis. The presence of MAC (p<0.001) as well as LA diameter (p<0.0001), LAAV of <30 cm/s (p<0.0001), PV flow systolic wave velocity (p<0.0001), and LASEC (p<0.0001) were detected as independent predictors of recurrence. In the receiver operating characteristic analysis, LAAV of >30 cm/s had a sensitivity of 85% and a specificity of 95% for predicting success after ablation (AUC=0.813; 95% CI:0.76–0.92; p<0.0001). CONCLUSION: The presence of MAC, increased LA diameter, the existence of LASEC, low LAAV, and low peak PV systolic wave velocity are parameters that can predict the recurrence of AF after cryoablation.
format Online
Article
Text
id pubmed-5331394
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-53313942017-06-28 Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation Menekşe Gerede, Demet Candemir, Başar Vurgun, Veysel Kutay Aghdam, Siamak Mousavi Acıbuca, Aynur Özcan, Özgür Ulaş Göksülük, Hüseyin Kervancıoğlu, Celal Erol, Çetin Anatol J Cardiol Original Investigation OBJECTIVE: The purpose of this study was to investigate the factors predicting the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation (PAF) who underwent cryoablation of the pulmonary veins (PVs). METHODS: Fifty-one patients (54.6±10.4 years) with paroxysmal AF who underwent the cryoablation of the PVs were to the prospective trial. The clinical risk factors and echocardiographic parameters [left atrial (LA) diameter, left ventricular ejection fraction and dimensions, left atrial spontaneous echo contrast (LASEC), mitral annulus calcification (MAC), left atrial appendage emptying peak flow velocity (LAAV), and PV flow] were assessed before the cryoablation procedure. Patients with PAF who refused to use any medication because of intolerance or presentation of resistant symptoms, despite the use of at least one antiarrhythmic drug were enrolled to the study, patients with LA/LAA thrombus on echocardiographic examination, severe valvular disease, pericardial fluid, and abnormal thyroid function tests as well as systemic disease were excluded from the study. All parameters were tested for their ability to predict the recurrence of AF during a 1-year follow-up period. RESULTS: During the period of follow-up, AF recurred in 16 of 51 patients (31.3%/year). All significant parameters associated with the recurrence of AF were evaluated in multivariate logistic regression analysis. The presence of MAC (p<0.001) as well as LA diameter (p<0.0001), LAAV of <30 cm/s (p<0.0001), PV flow systolic wave velocity (p<0.0001), and LASEC (p<0.0001) were detected as independent predictors of recurrence. In the receiver operating characteristic analysis, LAAV of >30 cm/s had a sensitivity of 85% and a specificity of 95% for predicting success after ablation (AUC=0.813; 95% CI:0.76–0.92; p<0.0001). CONCLUSION: The presence of MAC, increased LA diameter, the existence of LASEC, low LAAV, and low peak PV systolic wave velocity are parameters that can predict the recurrence of AF after cryoablation. Kare Publishing 2016-07 2015-09-15 /pmc/articles/PMC5331394/ /pubmed/26680545 http://dx.doi.org/10.5152/AnatolJCardiol.2015.6309 Text en Copyright © 2016 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Investigation
Menekşe Gerede, Demet
Candemir, Başar
Vurgun, Veysel Kutay
Aghdam, Siamak Mousavi
Acıbuca, Aynur
Özcan, Özgür Ulaş
Göksülük, Hüseyin
Kervancıoğlu, Celal
Erol, Çetin
Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
title Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
title_full Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
title_fullStr Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
title_full_unstemmed Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
title_short Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
title_sort prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331394/
https://www.ncbi.nlm.nih.gov/pubmed/26680545
http://dx.doi.org/10.5152/AnatolJCardiol.2015.6309
work_keys_str_mv AT meneksegerededemet predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT candemirbasar predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT vurgunveyselkutay predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT aghdamsiamakmousavi predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT acıbucaaynur predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT ozcanozgurulas predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT goksulukhuseyin predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT kervancıoglucelal predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation
AT erolcetin predictionofrecurrenceaftercryoballoonablationtherapyinpatientswithparoxysmalatrialfibrillation